Anti-Xa activity after subcutaneous administration of dalteparin in ICU patients with and without subcutaneous oedema: a pilot study

INTRODUCTION: Intensive care unit (ICU) patients often suffer from subcutaneous oedema, due to administration of large fluid volumes and the underlying pathophysiological condition. It is unknown whether the presence of subcutaneous oedema impairs the absorption of dalteparin, a low molecular weight...

Descripción completa

Detalles Bibliográficos
Autores principales: Rommers, Mirjam K, Van Der Lely, Netty, Egberts, Toine CG, van den Bemt, Patricia MLA
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550968/
https://www.ncbi.nlm.nih.gov/pubmed/16790078
http://dx.doi.org/10.1186/cc4952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550968/
https://www.ncbi.nlm.nih.gov/pubmed/16790078
http://dx.doi.org/10.1186/cc4952

Ejemplares similares